Form 4: McKesson Corp Executive LeAnn B Smith Reports Stock Sale and RSU Vesting

Sentiment:

SEC Form 4 Filing


LeAnn B Smith, EVP & Chief HR Officer of McKesson Corp, reports the sale of 704 shares of common stock and the vesting of 678 Restricted Stock Units (RSUs) on May 23, 2024.

Summary

  • On May 23, 2024, LeAnn B Smith, EVP & Chief HR Officer of McKesson Corp, reported transactions involving the company's common stock.
  • Smith sold 704 shares of common stock at a price of $558.09 per share.
  • Additionally, 678 Restricted Stock Units (RSUs) vested on the same date.
  • 267 shares were withheld to cover taxes related to the RSU vesting at a price of $558.03.
  • The sale of shares was executed pursuant to a Rule 10b5-1(c) trading arrangement dated November 3, 2023.
  • Following these transactions, Smith directly owns 2,626 shares of McKesson Corp common stock and 1,357 Restricted Stock Units.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transactions appear to be routine and pre-planned, with no indication of unusual activity or concern.

Positives

  • The transactions were executed under a pre-arranged trading plan (Rule 10b5-1(c)), which can mitigate concerns about insider trading.

Risks

  • Executive stock sales can sometimes be perceived negatively by investors, although this sale was pre-planned.

Future Outlook

The remaining RSUs will vest in two equal installments on May 23, 2025, and May 23, 2026.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and RSUs to align management's interests with those of shareholders.
  • Rule 10b5-1 trading plans are a standard practice to allow insiders to sell shares without concerns about insider trading violations.
  • Comparing Smith's holdings and transactions to those of executives at similar companies like CVS Health or UnitedHealth Group could provide a broader context.

Stakeholder Impact

  • The stock sale could have a minor impact on shareholders if it signals a lack of confidence, although the pre-planned nature mitigates this concern.
  • The RSU vesting is a part of Smith's compensation package and incentivizes her to contribute to the company's success.

Next Steps

  • Monitor future Form 4 filings by LeAnn B Smith and other McKesson Corp executives for further insights into their stock ownership and trading activity.

Key Dates

DateDescription
November 3, 2023Date of the Rule 10b5-1(c) trading arrangement.
May 23, 2024Date of the stock sale and RSU vesting.
May 23, 2025Date of the next 1/3 RSU vesting.
May 23, 2026Date of the final 1/3 RSU vesting.
May 28, 2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.